Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Shares Issued (2021 - 2025)

Journey Medical (DERM) has disclosed Shares Issued for 5 consecutive years, with $103000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued fell 6.36% year-over-year to $103000.0, compared with a TTM value of $341000.0 through Sep 2025, up 11.8%, and an annual FY2024 reading of $207000.0, up 71.07% over the prior year.
  • Shares Issued was $103000.0 for Q3 2025 at Journey Medical, down from $141000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $32.5 million in Q4 2021 and bottomed at -$2000.0 in Q4 2024.
  • Average Shares Issued over 5 years is $2.8 million, with a median of $90500.0 recorded in 2023.
  • The sharpest move saw Shares Issued plummeted 102.08% in 2024, then surged 907.14% in 2025.
  • Year by year, Shares Issued stood at $32.5 million in 2021, then tumbled by 99.9% to $31000.0 in 2022, then soared by 209.68% to $96000.0 in 2023, then tumbled by 102.08% to -$2000.0 in 2024, then skyrocketed by 5250.0% to $103000.0 in 2025.
  • Business Quant data shows Shares Issued for DERM at $103000.0 in Q3 2025, $141000.0 in Q2 2025, and $99000.0 in Q1 2025.